Tilki D - Search Results

1

Correction: Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities.

Stolzenbach LF, Löcherbach F, Wargenau K, Pose R, Steuber T, Tian Z, Budäus L, Tilki D, Graefen M, Köhler D, Karakiewicz PI, Sauer M, Apostolova II, Maurer T, Berliner C. Stolzenbach LF, et al. Among authors: tilki d. Nuklearmedizin. 2021 Sep 3. doi: 10.1055/a-1626-6669. Online ahead of print. Nuklearmedizin. 2021. PMID: 34479375 English. No abstract available.

2

Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.

Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A. Tilki D, et al. BJU Int. 2013 Jun;111(8):1215-21. doi: 10.1111/j.1464-410X.2012.11455.x. Epub 2012 Nov 26. BJU Int. 2013. PMID: 23181623

3

Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis.

Messer JC, Shariat SF, Dinney CP, Novara G, Fradet Y, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Lotan Y, Skinner EC, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Wei C, Lerner SP, Curiel TJ, Kamat AM, Svatek RS. Messer JC, et al. Among authors: tilki d. Urology. 2014 Apr;83(4):863-7. doi: 10.1016/j.urology.2013.10.060. Epub 2014 Jan 31. Urology. 2014. PMID: 24485993

4

Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy.

Michl U, Molfenter F, Graefen M, Tennstedt P, Ahyai S, Beyer B, Budäus L, Haese A, Heinzer H, Oh SJ, Salomon G, Schlomm T, Steuber T, Thederan I, Huland H, Tilki D. Michl U, et al. Among authors: tilki d. J Urol. 2015 Feb;193(2):479-83. doi: 10.1016/j.juro.2014.08.111. Epub 2014 Sep 6. J Urol. 2015. PMID: 25196656

5

Additional androgen deprivation makes the difference: Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapy.

Schiffmann J, Lesmana H, Tennstedt P, Beyer B, Boehm K, Platz V, Tilki D, Salomon G, Petersen C, Krüll A, Graefen M, Schwarz R. Schiffmann J, et al. Among authors: tilki d. Strahlenther Onkol. 2015 Apr;191(4):330-7. doi: 10.1007/s00066-014-0794-y. Epub 2014 Dec 4. Strahlenther Onkol. 2015. PMID: 25471276 Clinical Trial.

6

External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort.

Tilki D, Mandel P, Schlomm T, Chun FK, Tennstedt P, Pehrke D, Haese A, Huland H, Graefen M, Salomon G. Tilki D, et al. J Urol. 2015 Jun;193(6):1970-5. doi: 10.1016/j.juro.2014.12.020. Epub 2014 Dec 11. J Urol. 2015. PMID: 25498570

7

Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria.

Mandel P, Steuber T, Ahyai S, Kriegmair M, Schiffmann J, Boehm K, Heinzer H, Michl U, Schlomm T, Haese A, Huland H, Graefen M, Tilki D. Mandel P, et al. Among authors: tilki d. BJU Int. 2016 Jan;117(1):55-61. doi: 10.1111/bju.13103. Epub 2015 May 11. BJU Int. 2016. PMID: 25711672

8

The effect of age on functional outcomes after radical prostatectomy.

Mandel P, Graefen M, Michl U, Huland H, Tilki D. Mandel P, et al. Among authors: tilki d. Urol Oncol. 2015 May;33(5):203.e11-8. doi: 10.1016/j.urolonc.2015.01.015. Epub 2015 Mar 24. Urol Oncol. 2015. PMID: 25814146

9

Centralization and Quality Control of Elective Surgery Improve Outcome: Aren't We Ethically Obliged to Force the Pace of Creating High-volume Centers?

Tilki D, Huland H, Graefen M. Tilki D, et al. Eur Urol. 2015 Jul;68(1):30-1. doi: 10.1016/j.eururo.2015.03.032. Epub 2015 Mar 26. Eur Urol. 2015. PMID: 25817917 No abstract available.

10

Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility.

Schiffmann J, Wenzel P, Salomon G, Budäus L, Schlomm T, Minner S, Wittmer C, Kraft S, Krech T, Steurer S, Sauter G, Beyer B, Boehm K, Tilki D, Michl U, Huland H, Graefen M, Karakiewicz PI. Schiffmann J, et al. Among authors: tilki d. Urol Oncol. 2015 Jul;33(7):329.e13-9. doi: 10.1016/j.urolonc.2015.04.004. Epub 2015 May 7. Urol Oncol. 2015. PMID: 25960411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

566 results

Search Page